60 results
Page 2 of 3
8-K
EX-1.1
3q6kb5pb8 gmh72
25 Jun 21
Entry into a Material Definitive Agreement
5:05pm
424B5
mp29 9o3uu6hnw8
24 Jun 21
Prospectus supplement for primary offering
4:25pm
424B5
6zrs1x4vj2kk
22 Jun 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
zvukx7tuappkjvi56y
10 May 21
Entry into a Material Definitive Agreement
4:49pm
PRE 14A
638buxj pqt
14 Apr 21
Preliminary proxy
5:16pm
8-K
EX-99.1
p7j c97dj
11 Mar 21
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:34am
8-K
EX-1.1
0ifxwhv26vbgk
31 Jul 20
Entry into a Material Definitive Agreement
5:21pm
424B5
chjwg0mk8i6d4b
31 Jul 20
Prospectus supplement for primary offering
10:45am
424B5
88l7lww jbhxcrr
27 Jul 20
Prospectus supplement for primary offering
4:36pm
8-K
EX-10.2
b0x6bgz 4b
21 May 20
Departure of Directors or Certain Officers
4:13pm